<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124355">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01878773</url>
  </required_header>
  <id_info>
    <org_study_id>UHN REB 12-5229-CE</org_study_id>
    <nct_id>NCT01878773</nct_id>
  </id_info>
  <brief_title>Prostate Delineation: High Quality Volume CT</brief_title>
  <official_title>Prostate Delineation During Radiation Treatment Planning for Prostate Cancer: Comparison of High Quality Volume Computerized Tomography With Conventional Tomography and Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Princess Margaret Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will look at how feasible it is to use a certain type of Computed Tomography (CT)
      to scan prostate cancer, called a high quality volume CT scan. It is hoped that this
      technique will help doctors provide a higher-quality image of the prostate cancer, making it
      easier to plan the area that will be treated. Using this type of CT scan will also lessen
      the amount of time patients spend in the scanner.

      This study will not offer patients a different treatment for their prostate cancer. Patients
      will receive the most appropriate standard treatment whether or not they are in this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Using different scanning methods for patients undergoing radical external beam radiotherapy for prostate cancer to determine inter-observer variability in prostate gland delineation on the images.</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the concordance between delineators in identifying the prostate apex on the 2 CT image sets. MRI will be considered the &quot;gold-standard&quot; for identifying the prostate apex.</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>High Quality Volume CT Scan; MRI Scan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI Scan.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Quality Volume CT Scan; MRI Scan</intervention_name>
    <description>Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI scan.
--------------------------------------------------------------------------------</description>
    <arm_group_label>High Quality Volume CT Scan; MRI Scan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. At least 18 years old

          2. Subjects undergoing radical external beam radiotherapy for prostate cancer

          3. Ability to provide written informed consent

        Exclusion Criteria:

          1. Age â‰¤ 18 years

          2. Subjects not suitable for MRI scanning

          3. 3 usable image sets not obtained during treatment planning scans.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Charles Catton, MD</last_name>
    <phone>416 946 4501</phone>
    <phone_ext>2121</phone_ext>
    <email>Charles.Catton@rmp.uhn.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hamideh Alasti, PhD</last_name>
    <phone>416 946 4501</phone>
    <phone_ext>5812</phone_ext>
    <email>Hamideh.Alasti@rmp.uhn.on.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Health Network, The Princess Margaret</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Catton, MD</last_name>
      <phone>416 946 4501</phone>
      <phone_ext>2121</phone_ext>
      <email>Charles.Catton@rmp.uhn.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Hamideh Alasti, PhD</last_name>
      <phone>416 946 4501</phone>
      <phone_ext>5812</phone_ext>
      <email>hamideh.Alasti@rmp.uhn.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Catton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 3, 2014</lastchanged_date>
  <firstreceived_date>October 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate Cancer</keyword>
  <keyword>MRI scan</keyword>
  <keyword>External beam radiotherapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
